A study of rivastigmine liposomes for delivery into the brain through intranasal route.
about
Biomaterials for the Treatment of Alzheimer's DiseaseNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseGetting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrierNanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis.New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.Nanomaterial-mediated CNS delivery of diagnostic and therapeutic agents.Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Micellar nanomedicine of human neuropeptide Y.Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation.Ufasomes nano-vesicles-based lyophilized platforms for intranasal delivery of cinnarizine: preparation, optimization, ex-vivo histopathological safety assessment and mucosal confocal imaging.Brain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.Potential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer's disease.Drug delivery strategies for Alzheimer's disease treatment.The future of glioma treatment: stem cells, nanotechnology and personalized medicine.Intranasal therapeutic strategies for management of Alzheimer's disease.Development of a dual nanocarrier system as a potential stratagem against amyloid-induced toxicity.Liposomes for Targeted Delivery of Active Agents against Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease).A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson's disease.Rivastigmine-loaded L-lactide-depsipeptide polymeric nanoparticles: decisive formulation variable optimization.Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route.Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies.Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease.Comparative study between simple and optimized liposomal dispersion of quetiapine fumarate for diffusion through nasal route.Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization.A Stability Indicating HPLC Assay Method for Analysis of Rivastigmine Hydrogen Tartrate in Dual-Ligand Nanoparticle Formulation Matrices and Cell Transport Medium.Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer CellsPhyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities
P2860
Q26744462-003E4F9B-D4BC-461B-B05B-D4F8AF355451Q26783306-E0E2648F-4134-4DF6-A82B-434E551FE18CQ28071873-6BC75172-485E-4914-9169-A08FD735F034Q33622573-CFD44574-AE4A-4DB2-9DB0-FFDFBF413FD4Q33792474-69F3930E-B5DF-461B-81D4-FFF604B58B65Q34104503-5B88B5F8-05F2-40B2-8434-3A8C6B6AC759Q34383339-58F90DCC-97F3-4D60-B876-F285878A7FCCQ35000999-D119AF35-9405-43DD-A2A7-CCFF6387EBF4Q35567800-FE022929-38E4-4BF0-9741-DB9FBACFD82FQ35638055-31F6A320-A9BC-4F98-A6CB-ACD803BE23B8Q36052412-C32F4955-ACAD-4549-AA72-4B00EB84C9E8Q36081720-D799E7B3-E86C-46A6-BC19-9DB59922E7CBQ36571755-9E64CB4A-D2BA-41F0-935F-F0F8D739CA92Q37851509-5CA11265-4591-40D8-8610-4E51BB633B3BQ38048888-245FF61C-35CC-44DE-99FA-99338463BEADQ38176935-88F5A6D0-FABF-444C-91C7-1F18EA9A6039Q38996889-D500C2C5-1F4E-4887-AC0E-C39CBCE01A8DQ39803583-EF5365B1-3053-4F8C-B7FE-AD552FF91C14Q42183169-D492B993-8F88-4C23-8DE0-8C1C9D97C8FDQ42256432-C9F1DB5C-22E3-4E00-A5C2-47EC7B9AFAD8Q42315487-B87E32ED-3DED-41C7-964A-6495A1AAC283Q43083731-C3A5BDE9-610E-4CCD-95D0-FD55E5DED391Q46526710-74BA0F24-4AB7-4890-8518-A5858A2E8A5CQ47724056-A923C00F-77E0-4A29-A8D4-3CD716BD61C2Q52145252-39358670-3010-4AEE-9E1C-0F1349B8BFA6Q52654049-08E69820-783D-40AE-A403-2E02CC32CC25Q53460577-B36A7462-D5EF-4CE2-8841-DD64AAE8F31CQ55042429-C6B01815-99C1-4CF8-9723-A63F9154539AQ57826028-CA0DD306-94FE-43DC-AD7B-1DBDFCFEC48AQ58571824-A46D5D31-0CD9-4D64-89E7-63DDEEFD5BFF
P2860
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
@en
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
@nl
type
label
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
@en
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
@nl
prefLabel
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
@en
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
@nl
P2093
P2860
P1433
P1476
A study of rivastigmine liposomes for delivery into the brain through intranasal route.
@en
P2093
Ganesa Sundararajan Subramanian
Karthik Arumugam
Meka Sreenivasa Reddy
Ranjith Kumar Averineni
Surulivel Rajan Mallayasamy
P2860
P304
P356
10.2478/V10007-008-0014-3
P577
2008-09-01T00:00:00Z